Article Name North America
Company Committed to Support U.S. Health Care Needs
04th December, 2023
Supported by US India SME Council for Expansion into US Markets
06th November, 2023
Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer, and more fulfilling, announced that the American Medical Association (AMA) will issue two new Category I Current Procedural Terminology (CPT®) codes for the iTind™ procedure, a minimally invasive treatment for men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
22nd October, 2023
Collaboration leverages two CDx assays from Thermo Fisher to support greater access to genomic testing for cancer patients in Japan and the United States
20th October, 2023
Rapid Detection of Modern Blood Thinners Could Reduce Preventable Complications in US Hospitals
19th October, 2023
-joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, launched its new iLESSYS® Biportal Interlaminar Endoscopic Surgical System for the treatment of spinal disorders at the EUROSPINE 2023 Annual Meeting in Frankfurt and at the SMISS Annual Forum (Society for Minimally Invasive Spine Surgery) in Las Vegas, marking its global debut
17th October, 2023
New Reagent Aids in Diagnosis of Connective Tissue Disease in Hard-to-Diagnose Autoimmune Diseases, Reducing Time to Diagnosis and Improving Patient Outcomes
17th October, 2023
UL Solutions helps Michigan's growing medical device industry enhance products' safety, security, usability and interoperability with new testing services in Rochester Hills.
13th October, 2023
FirstLook Lung uses a breakthrough technology of whole-genome machine learning to analyze fragments of cell-free DNA that are markers of cancer in the blood
11th October, 2023
Rhaeos, Inc, a clinical stage medical device technology company, is pleased to announce that it has been awarded a $1.5 million grant (Federal Award # 1UG3NS130338) from the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) through its Blueprint MedTech program. This grant will further the development of its FDA breakthrough designated medical technology designed to transform the management of hydrocephalus, a neurological condition affecting over one million Americans.
11th October, 2023
Platform will ease administrative burdens and improve healthcare facility management and patient care
09th October, 2023
Company Continues to Build Momentum with Most Recent Portfolio Expansion.
28th September, 2023
Patients implanted with the Evoke® System now eligible for full-body MRI scans
27th September, 2023
The partnership provides access to hospitals in Australia, New Zealand, Thailand, Philippines, Taiwan, Hong Kong, Malaysia, Pakistan, Singapore and Vietnam
25th September, 2023
The startup develops and provides PidPort, an AI-powered cloud system that supports digital pathology
25th September, 2023
Bio-Gate AG (ISIN DE000BGAG981), a leading provider of innovative technologies and individual solutions for health and hygiene, has concluded a preliminary agreement (LOI, Letter-of-Intent) with a North American medical device manufacturer focusing on the trauma sector. The medical device manufacturer intends to use Bio-Gate's "HyProtectTM " coating process for its own implants in human medicine following the FDA approval process.
22nd August, 2023
Company Adds Key Products to its Comprehensive Cervical Spine Portfolio
16th August, 2023
CareBand, a pioneer in low-powered location-based health and safety wearable solutions, celebrates the granting of US Patent No 11,714,197. This milestone further strengthens CareBand's position as a leading innovator in the rapidly growing LPWAN market.
16th August, 2023
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer